Q1 2020 Syndax Pharmaceuticals Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. And welcome to the Syndax First Quarter 2020 Conference Call. (Operator Instructions) Please be advised today's conference is being recorded. (Operator Instructions) I would now like to hand the conference over to your speaker today, Melissa Forst with Argot Partners. Thank you. Please go ahead now.
Thank you, operator. Welcome. And thank you to those of you joining us on the line and the webcast this afternoon for a review of Syndax' first quarter 2020 financial and operating results.
I'm Melissa Forst of Argot Partners and with me this afternoon to discuss the results and provide an update on the company's progress are Dr. Briggs Morrison, Chief Executive Officer; and Rick Shea, Chief Financial Officer. Also joining us on the call for the question-and-answer session is Michael Metzger, President and COO; Dr. Michael Meyers, Chief Medical Officer; and Dr. Peter Ordentlich, Chief Scientific Officer.
This call is being accompanied by a slide deck that has
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |